These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23905613)

  • 21. Comparison of hydration reactions for "piano-stool" RAPTA-B and [Ru(η6-arene)(en)Cl]+ complexes: density functional theory computational study.
    Chval Z; Futera Z; Burda JV
    J Chem Phys; 2011 Jan; 134(2):024520. PubMed ID: 21241133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles.
    Mitra R; Das S; Shinde SV; Sinha S; Somasundaram K; Samuelson AG
    Chemistry; 2012 Sep; 18(39):12278-91. PubMed ID: 22903299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in ruthenium anticancer drugs.
    Levina A; Mitra A; Lay PA
    Metallomics; 2009 Nov; 1(6):458-70. PubMed ID: 21305154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strained ruthenium complexes are potent light-activated anticancer agents.
    Howerton BS; Heidary DK; Glazer EC
    J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
    Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An insight into the anticancer activities of Ru(II)-based metallocompounds using docking methods.
    Adeniyi AA; Ajibade PA
    Molecules; 2013 Sep; 18(9):10829-56. PubMed ID: 24008244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electron-structure calculations and bond order analysis using density functional theory of cationic dinuclear arene ruthenium complexes.
    Fowe EP; Therrien B; Süss-Fink G; Daul C
    Inorg Chem; 2008 Jan; 47(1):42-8. PubMed ID: 18052334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DFT Simulation of Structural and Optical Properties of 9-Aminoacridine Half-Sandwich Ru(II), Rh(III), and Ir(III) Antitumoral Complexes and Their Interaction with DNA.
    Cerón-Carrasco JP; Ruiz J; Vicente C; de Haro C; Bautista D; Zúñiga J; Requena A
    J Chem Theory Comput; 2017 Aug; 13(8):3898-3910. PubMed ID: 28641006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
    Wang F; Xu J; Habtemariam A; Bella J; Sadler PJ
    J Am Chem Soc; 2005 Dec; 127(50):17734-43. PubMed ID: 16351102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metal-metal interactions in linear tri-, penta-, hepta-, and nona-nuclear ruthenium string complexes.
    Niskanen M; Hirva P; Haukka M
    J Mol Model; 2012 May; 18(5):1961-8. PubMed ID: 21870194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
    Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
    Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electronic structure of oxidized complexes derived from cis-[Ru(II)(bpy)2(H2O)2]2+ and its photoisomerization mechanism.
    Planas N; Vigara L; Cady C; Miró P; Huang P; Hammarström L; Styring S; Leidel N; Dau H; Haumann M; Gagliardi L; Cramer CJ; Llobet A
    Inorg Chem; 2011 Nov; 50(21):11134-42. PubMed ID: 21992177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theoretical investigation on second-order nonlinear optical properties of ruthenium alkynyl-dihydroazulene/vinylheptafulvene complexes.
    Jing LX; Wang L; Ye JT; Chen ZZ; Chen H; Qiu YQ
    J Mol Graph Model; 2017 Oct; 77():363-371. PubMed ID: 28946068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
    Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
    Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
    J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
    Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
    Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electronic structures of ruthenium and osmium complexes of 9,10-phenanthrenequinone.
    Biswas MK; Patra SC; Maity AN; Ke SC; Adhikary ND; Ghosh P
    Inorg Chem; 2012 Jun; 51(12):6687-99. PubMed ID: 22663598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the [CpM(CO)2](-) chromophore in the optical properties of the [Cp2ThMCp(CO)2](+) complexes, where M = Fe, Ru and Os. A theoretical view.
    Cantero-López P; Le Bras L; Páez-Hernández D; Arratia-Pérez R
    Dalton Trans; 2015 Dec; 44(46):20004-10. PubMed ID: 26523807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
    Bíró L; Farkas E; Buglyó P
    Dalton Trans; 2012 Jan; 41(1):285-91. PubMed ID: 22051630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.